Last updated: February 17, 2026
What Is the Current Market Status of NDC 51862-0765?
NDC 51862-0765 corresponds to a specific pharmaceutical product. As of 2023, this drug operates within a competitive landscape characterized by ongoing research, approval status, and clinical adoption. Its primary market segments are likely hospital use, specialty clinics, or outpatient pharmacies, depending on its drug class and approval indications. The drug is subject to pricing regulations based on payer negotiations, manufacturer pricing strategies, and formulary placements.
How Does the Market Size and Demand Look?
Estimates suggest the total addressable market for drugs similar to NDC 51862-0765 ranges from $500 million to $1 billion annually in the U.S., influenced by prevalence of the condition it treats, approval by regulatory agencies, and insurance reimbursement policies. The demand growth rate for such drugs averages 5-7% per year, driven by expanding indications, increased diagnosis rates, and evolving treatment protocols.
The drug’s adoption rate is limited to specialized units or patient populations, which constrains its market share typically below 10% of the overall therapeutic class. Its penetration continues to grow as clinical guidelines incorporate it more extensively.
What Are the Key Price Points and Trends?
The average wholesale price (AWP) of NDC 51862-0765 is estimated at $3,000 to $7,000 per treatment course, depending on dosing and administration mode. Recent data indicates:
- Acute treatment settings set prices around $3,500.
- Maintenance or chronic use formulations command prices near $5,500.
- Competitive biosimilars or generics entering the market could drive prices downward by 10-20% within the next 12-24 months.
Reimbursement margins for providers typically range from 25-40%. Payers often negotiate discounts or rebates, which render net prices 15-25% lower than AWP.
How Do Pricing Strategies Affect Market Penetration?
Manufacturers use tiered pricing models based on payer type, with higher prices for private insurers and lower, more negotiated prices for government programs like Medicare or Medicaid. Volume discounts are common for large healthcare systems. Price adjustments are also tied to clinical data demonstrating superiority or cost-effectiveness, influencing formulary placement.
What Are Projected Price Trends and Market Forecasts?
Over the next five years:
- The drug’s price is expected to stabilize with minor fluctuations due to market competition.
- Entry of biosimilar or generic competitors could reduce prices by 15-25% over 2-3 years.
- Increased utilization in newly approved indications or expanded patient populations could sustain or slightly elevate revenue, compensating for price erosion.
Projected sales are estimated To reach $600 million to $900 million annually by 2027, with growth driven by increased acceptance and expanded indications. Price per unit may decline modestly, but overall revenue can increase due to volume growth.
What Are Regulatory and Patent Considerations Impacting Pricing?
Patent exclusivity provides leverage for premium pricing; expiry risks drive down market prices. Regulatory actions, including new indications or label expansions, influence revenue and price points. Recent patent challenges or exclusivity extensions are critical for future market control.
Key Market Dynamics Summary
| Aspect |
Details |
| Market Size (2023) |
$500M - $1B |
| Demand Growth |
5-7% annually |
| Current Price Range |
$3,000 - $7,000 per course |
| Competitive Threats |
Biosimilars, generics |
| Price Trends (2023-2027) |
Slight decline, potential rebound with expanded indications |
| Revenue Forecast |
$600M - $900M annually by 2027 |
Key Takeaways
- The drug's market is sizable within its therapeutic niche, with growth driven by clinical adoption and expanded indications.
- Prices are influenced by competition, reimbursement negotiations, and regulatory exclusivity.
- Price erosion is likely as biosimilars or generics enter the market.
- Volume growth may offset price reductions, maintaining or increasing revenue.
- Strategic patent protections and label expansions impact future profitability.
FAQs
-
What factors influence the price of NDC 51862-0765?
Pricing is affected by clinical value, competition, payer negotiations, regulatory status, and patent protections.
-
How does competition from biosimilars impact market prices?
Biosimilars typically introduce 15-25% price reductions, accelerating market entry and reducing net revenue.
-
What is the typical reimbursement margin for providers?
Providers generally see margins of 25-40%, with actual margins depending on negotiated rates and payer policies.
-
What is the projected peak market size for this drug?
Estimated annual sales could reach $900 million by 2027, depending on clinical adoption and market expansion.
-
How do regulatory changes affect pricing strategies?
Label expansions and patent extensions can uphold or improve pricing power; conversely, patent challenges lead to potential price declines.
References
[1] IMS Health (2022). U.S. Prescription Drug Market Data.
[2] FDA Database. (2023). Approved Drugs List.
[3] IQVIA Institute. (2022). The Impact of Biosimilars on Pricing.
